We anticipate that the sample will be representative of the populations in our ongoing trials of clients with substance use disorders and of the substance abuse treatment population, which is approximately 70% male, 60% African-American, 35% Caucasian, and 30% Hispanic. This distribution is similar to the gender and racial distributions of publicly funded drug abuse treatment patients in Philadelphia and other large cities located in Mid-Atlantic States.